Dermatology EMR Software Market - Size, Share,
Outlook, and Opportunity Analysis, 2018 – 2026
Electronic medical records (EMRs) is a part of Electronic Health Records (EHR). Dermatology
outpatients include large number of patients with chronic diseases since they need long follow-
up durations for cure. Therefore, EMRs in dermatology will be useful in recording
dermatological data. EMRs in dermatology also allows streamlined, one-click retrieval of old
records, previous investigation reports, medical bills, X-rays, and graphics of affected area on
body on which the dermatologist can analyze skin lesions along with rashes, and ulcers.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2240
Dermatology EMR Software Market: Drivers
Increasing awareness for use of EMRs in healthcare sector is expected to propel growth of the
dermatology EMR software market. For instance, in November 2017, the Dubai Health Authority
(DHA) completed the third and final phase of the unified electronic medical record (EMR)
system Salama, in Latifa Hospital, Hatta Hospital, Thalassemia Centre, Dubai Gynecology and
Fertility Centre, and all DHA Medical Fitness Centers across the United Arab Emirates (UAE).
Salama stores vital patient information such as the medical history of the patient, past surgery
details, lab test results, and X-ray reports, which can be easily accessed by any DHA doctor
from all DHA facilities across the UAE region.
Moreover, in September 2018, MedX Health Corp., a Canadian company, launched DermSecure,
its telemedicine platform, in six Ontario clinics. DermSecure telemedicine platform offers
benefits to patients and primary care physicians by working with dermatologists for enhancing
their skills in terms of disease diagnosis and treatment.
Furthermore, Apple Inc., in April 2018, launched Apple Health Records feature that combines
data of patients’ current heath and data from their past EHR in the health app by using HL7’s
Fast Healthcare Interoperability Resource (FHIR) specification. This allow users to know about
their drug allergies, medications, and precautions during treatment. It also allow patients to